Difference between revisions of "Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 (Q9838)"

@@ Property / Publication Date @@
+Timestamp +2011-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2011-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2011 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+J. Clin. Oncol.
@@ Property / Published In Name String: J. Clin. Oncol. / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 29 / rank @@
+Normal rank
@@ Property / title @@
+Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
+Normal rank
@@ Property / Page(s) @@
+-3534
@@ Property / Page(s): 3529-3534 / rank @@
+Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8